V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10004505 | 10002848 | 0 | 69.8 | Palliative (P) | 2018-03-14 | 2018-03-26 | AML16 DA 3+10 | N | N | 10531127 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 10004506 | 10002849 | 0 | 85.3 | Curative (C) | 2019-03-28 | 2019-03-31 | GEFITINIB | 2 | N | 10531378 | CISPLATIN + FLUOROURACIL |
| 10004507 | 10002850 | 1.6 | null | Neo-adjuvant (N) | 2017-04-30 | 2017-05-14 | RUXOLITINIB | Y | Y | 10531519 | CARBOPLATIN + RT |
| 10004508 | 10002851 | null | 66.9 | Adjuvant (A) | 2018-03-02 | 2018-03-31 | FLUOROURACIL + MITOMYCIN | 02 | N | 10531527 | CISPLATIN + FLUOROURACIL + RT |
| 10004509 | 10002852 | 1.72 | null | Curative (C) | 2019-03-30 | 2019-04-05 | CETUXIMAB + RT | N | N | 10531615 | CAPECITABINE + MITOMYCIN |
| 10004510 | 10002853 | 1.72 | 60 | Disease modification (D) | 2018-03-22 | 2018-04-06 | Ipilimumab | 02 | N | 10531616 | DACARBAZINE |
| 10004511 | 10002853 | 1.62 | 77 | Disease modification (D) | 2014-08-13 | 2014-08-27 | TAC | N | N | 10531616 | FLUOROURACIL + RT |
| 10004512 | 10002854 | 1.7 | 83.1 | Palliative (P) | 2017-01-20 | 2017-02-02 | Sunitinib | N | N | 10531661 | NOT MATCHED |
| 10004513 | 10002854 | 1.66 | 147 | Curative (C) | 2016-08-29 | 2016-08-30 | CYCLOPHOSPHAMIDE + RITUXIMAB + Dexamethasone | N | N | 10531661 | CARBO + FLUOROURACIL |
| 10004514 | 10002855 | 0 | 80 | Palliative (P) | 2018-07-05 | 2018-07-05 | Cytarabine Low Dose | 01 | N | 10531672 | CETUXIMAB |
| 10004515 | 10002856 | 1.78 | 0 | Palliative (P) | 2018-12-06 | 2018-12-28 | DABRAFENIB + TRAMETINIB | 2 | N | 10531802 | CAPECITABINE + CARBOPLATIN |
| 10004516 | 10002857 | 1.55 | null | Palliative (P) | 2017-12-08 | 2017-12-22 | Mitomycin Intravesical | N | null | 10531827 | CARBOPLATIN + PACLITAXEL + RT |
| 10004517 | 10002858 | 1.56 | 51 | Palliative (P) | 2017-08-04 | 2017-08-29 | VISMODEGIB | N | Y | 10531876 | DACARBAZINE |
| 10004518 | 10002859 | 1.63 | null | Palliative (P) | 2017-02-20 | 2017-03-03 | Temozolomide 150mg/m2 | N | N | 10532035 | CETUXIMAB + IRINOTECAN + MDG |
| 10004519 | 10002860 | 1.61 | 57 | Curative (C) | 2017-02-22 | 2017-03-31 | Cyclophosphamide + Docetaxel | 02 | null | 10532112 | NEPTUNE TRIAL |
| 10004520 | 10002861 | 1.77 | 68 | Adjuvant (A) | 2016-04-01 | 2016-04-22 | Cetuximab + Oxaliplatin + MdG Load | null | null | 10532185 | MITOMYCIN INTRAVESICULAR |
| 10004521 | 10002862 | 1.69 | 68.2 | Palliative (P) | 2015-11-20 | 2015-11-25 | Cetuximab 7 day (Cycle 1) | 01 | N | 10532257 | SORAFENIB |
| 10004522 | 10002863 | 1.73 | 70 | Palliative (P) | 2016-03-30 | 2016-04-05 | Capecitabine + Mitomycin | 02 | N | 10532317 | SORAFENIB |
| 10004523 | 10002863 | 1.77 | 71.2 | Palliative (P) | 2016-10-14 | 2016-10-21 | GEMCITABINE + NAB PACLITAXEL | 02 | N | 10532317 | DABRAFENIB |
| 10004524 | 10002864 | null | 114 | Palliative (P) | 2017-08-26 | 2017-08-30 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 2 | N | 10532534 | CISPLATIN + FLUOROURACIL |
| 10004525 | 10002865 | null | 76.7 | Neo-adjuvant (N) | 2015-09-07 | 2015-09-07 | EP | 02 | N | 10532554 | CLARITY TRIAL |
| 10004526 | 10002866 | 1.68 | null | Curative (C) | 2017-03-02 | 2017-03-13 | Cetuximab 14 day | N | N | 10532561 | COMPLEMENT TRIAL |
| 10004527 | 10002867 | 1.7 | 0 | Adjuvant (A) | 2015-09-19 | 2015-10-13 | GEFITINIB | N | Y | 10532599 | BORTEZOMIB + THALIDOMIDE |
| 10004528 | 10002868 | 1.66 | 73.8 | Curative (C) | 2013-07-27 | 2013-07-28 | LANREOTIDE | 02 | N | 10532610 | BEVACIZUMAB |
| 10004529 | 10002869 | 1.95 | 80.8 | Palliative (P) | 2017-04-25 | 2017-05-01 | Bendamustine +/- Prednisolone | 02 | N | 10532623 | CETUXIMAB + RT |
| 10004530 | 10006658 | 1.7 | 78.5 | Palliative (P) | 2016-06-18 | 2016-07-01 | Folfirinox | N | N | 10532717 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB |
| 10004531 | 10006658 | 1.61 | 89.3 | Adjuvant (A) | 2017-12-06 | 2017-12-27 | IBRUTINIB | N | N | 10532717 | MPT |
| 10004532 | 10006658 | 1.65 | 59.1 | Palliative (P) | 2017-12-10 | 2017-12-10 | null | 2 | N | 10532717 | IXAZOMIB + LENALIDOMIDE |
| 10004533 | 10006658 | 1.8 | 62.2 | Palliative (P) | 2018-02-13 | 2018-02-13 | Vinorelbine (oral) | N | N | 10532717 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 10004534 | 10002870 | 0 | 75.6 | Palliative (P) | 2015-07-05 | 2015-07-06 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 02 | N | 10532947 | AML18 TRIAL |
| 10004535 | 10002871 | 1.83 | 53.8 | null | 2015-06-09 | 2015-06-30 | VISMODEGIB | N | N | 10532952 | CETUXIMAB |
| 10004536 | 10002872 | 1.79 | null | Palliative (P) | 2015-02-26 | 2015-02-26 | Capecitabine (14 day) + Irinotecan | N | N | 10533008 | NIVOLUMAB |
| 10004537 | 10006659 | 1.8 | 88 | Palliative (P) | 2018-10-21 | 2018-10-31 | RUXOLITINIB | 02 | N | 10533032 | QUASAR 2 TRIAL |
| 10004538 | 10006659 | 1.67 | 77.9 | Palliative (P) | 2017-02-11 | 2017-02-12 | Capecitabine (21days) + Carboplatin | N | N | 10533032 | IBRUTINIB |
| 10004539 | 10006659 | 1.77 | 98.3 | Palliative (P) | 2018-09-18 | 2018-09-20 | GEFITINIB | 2 | N | 10533032 | MPV |
| 10004540 | 10009119 | null | 91.1 | Palliative (P) | 2016-11-09 | 2016-11-16 | Folfirinox | N | N | 10533229 | ALEMTUZUMAB |
| 10004541 | 10009119 | 1.63 | 52.2 | Curative (C) | 2014-11-26 | 2014-12-15 | DABRAFENIB | N | N | 10533229 | ERLOTINIB |
| 10004542 | 10009119 | null | null | Disease modification (D) | 2015-06-29 | 2015-06-30 | AML16 Low Dose Cytarabine | N | N | 10533229 | ALEMTUZUMAB |
| 10004543 | 10009119 | 1.65 | 67 | Palliative (P) | 2018-02-08 | 2018-02-21 | Vincristine (weekly) | 02 | N | 10533229 | RITUXIMAB + VINBLASTINE |
| 10004544 | 10006660 | 1.84 | null | Palliative (P) | 2015-11-22 | 2015-12-05 | Ipilimumab | N | N | 10533409 | CHLORAMBUCIL + RITUXIMAB |
| 10004545 | 10002873 | 1.65 | 54.1 | Disease modification (D) | 2018-01-24 | 2018-01-29 | CYCLOPHOSPHAMIDE + RITUXIMAB | Y | N | 10533421 | DABRAFENIB |
| 10004546 | 10002874 | 1.59 | 57.1 | Palliative (P) | 2016-07-01 | 2016-07-08 | ICON8 TRIAL | N | N | 10533451 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 10004547 | 10002875 | 1.62 | 62 | Palliative (P) | 2016-05-06 | 2016-07-02 | Cyclophosphamide + Docetaxel | N | N | 10533457 | CARBO + DOCETAXEL + TRASTUZUMAB |
| 10004548 | 10002875 | null | 60.6 | Palliative (P) | null | 2018-11-21 | Gemcitabine+Paclitaxel (Neo-tAnGo) | N | N | 10533457 | CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| 10004549 | 10002876 | 1.57 | 83 | Not known (9) | 2015-02-27 | 2015-03-05 | CISPLATIN + VINORELBINE + RT | 01 | N | 10533550 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 10004550 | 10002877 | 1.71 | 60 | Disease modification (D) | 2015-03-11 | 2015-03-11 | Bevacizumab 7.5mg/kg | 02 | Y | 10533576 | AML19 TRIAL |
| 10004551 | 10002877 | 1.75 | 75.3 | Palliative (P) | 2016-04-20 | 2016-05-13 | Panitumumab | 02 | N | 10533576 | DACARBAZINE |
| 10004552 | 10002878 | 1.77 | null | Disease modification (D) | null | 2017-10-05 | MPT | Y | N | 10533748 | BENDAMUSTINE |
| 10004553 | 10002878 | 1.76 | 61 | Palliative (P) | 2017-01-15 | 2017-01-31 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | 10533748 | CHLORAMBUCIL + RITUXIMAB |
| 10004554 | 10002878 | null | null | Palliative (P) | 2018-10-27 | 2018-10-27 | Cladribine (subcut) 5 days | N | N | 10533748 | R-EPOCH |